SPECIALTY TOPICS · GUIDE
Cranial Electrical Stimulation: Educational Overview
What cranial electrical stimulation (CES) devices are, how FDA classifies them for anxiety, insomnia and depression, what trials report and what risks apply.
Content last updated . This page has not been medically reviewed.
Back to BiohackingWhat CES is
Cranial electrical stimulation (CES), also called cranial electrotherapy stimulation, uses a small device that sends a very low-level electrical current through electrodes on the head, often clipped to the ears. FDA's 2019 order describes a cranial electrotherapy stimulator as a prescription device that applies electrical current. [1] The reports of "ear discomfort and ear pain" in trials fit that ear-based design. [2]This page is an overview of the device category and its evidence. It does not give settings, session lengths or any instructions. For the research angle, see cranial electrical stimulation: research and status.
How FDA classifies CES in the United States
Source: a Federal Register final order, effective December 20, 2019.| Intended use | FDA class | What that means |
|---|---|---|
| Insomnia and/or anxiety | Class II (special controls) [1] | Devices must meet defined special controls |
| Depression | Class III (premarket approval) [1] | Needs premarket approval by FDA |
FDA's own risk list for CES devices used for anxiety or insomnia includes ineffective treatment, skin irritation, headaches, dizziness, and electrical shocks and burns. [1]
The depression category has a recent example. FDA's database lists the Flow FL-100, a tDCS headset, as a "cranial electrotherapy stimulator to treat depression" (regulation 882.5800), with a decision date of December 8, 2025. [3] That shows how FDA groups device types by regulation. It does not mean every CES or tDCS product is cleared or approved. See tDCS and tACS: educational overview for that device's details. Laws and classifications change and this is not legal advice. I did not verify rules outside the United States, or the clearance status of any particular CES product.
What trials report
- Anxiety. A 2022 systematic review and meta-analysis of 11 randomized trials (794 people) found CES lowered anxiety symptoms compared with control, with a moderate effect size (Hedges' g about -0.63). No severe side effects were reported, and the most common events were ear discomfort and ear pain. [2]
- Anxiety, depression and insomnia in people with anxiety. A 2023 meta-analysis of eight trials (337 participants) reported better outcomes than control for anxiety, depression and insomnia (the insomnia result came from three trials). [4] A subgroup of four trials of one device, named in the review as Alpha-Stim, also beat sham for anxiety. [4] This is a statement about that review, not a ranking or endorsement of a brand.
- Depression. The 2023 review above looked at depressive symptoms in people with anxiety, not people with depression as the main problem. [4]
Label for anxiety and insomnia: promising but limited. These are small trials, many with short follow-up. I read abstracts rather than full trial reports, so I cannot judge each trial's blinding or risk of bias. Because a sham device can still produce a sense of relief, read placebo and expectancy effects and clinical devices vs wellness gadgets.
Frequently asked questions
Is cranial electrical stimulation FDA approved?
It depends on the intended use. In 2019 FDA made devices for insomnia and/or anxiety Class II (special controls), and those for depression Class III (premarket approval). [1]
Does CES work for anxiety?
A 2022 meta-analysis of 11 randomized trials found a moderate reduction in anxiety symptoms versus control. [2] I rate this promising but limited.
Does CES help sleep?
A 2023 meta-analysis of three trials found improved insomnia outcomes in people with anxiety. [4] Evidence is thin.
What side effects occur?
Ear discomfort and pain were the most common in one review, with no severe effects reported. [2] FDA lists skin irritation, headaches, dizziness and burns as risks. [1]
Is CES the same as TMS or ECT?
No. These are different techniques; see electrical and magnetic brain stimulation: how they differ.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
How to read the evidence labels
Labels used on this page: regulated device (regulator, function and date named), promising but limited, mixed, insufficient evidence and marketing claim.
Safety and who should check first
- Known problems. Skin irritation, headaches, dizziness, shocks and burns are listed risks. [1]
- Not a substitute for care. Anxiety, ongoing insomnia and depression are health conditions worth professional evaluation. See anxiety disorders, insomnia and talking with a health professional. Do not stop or change prescribed medicine because of a device. If you are thinking about harming yourself, call or text 988 (US Suicide & Crisis Lifeline) or 911 in an emergency.
- Who to ask first. Anyone with epilepsy, an implanted medical device, skin problems at the electrode area, pregnancy or a heart condition should ask a clinician first. FDA's order sets prescription status for these devices. [1]
- Home-made or modified devices are never advisable; see DIY brain stimulation risks.
References
- U.S. Food and Drug Administration. Neurological Devices; Reclassification of Cranial Electrotherapy Stimulator Devices Intended To Treat Anxiety and/or Insomnia. Federal Register, December 20, 2019 (document 2019-27295). Read 2026-10-22.
- Efficacy and Tolerability of Cranial Electrotherapy Stimulation in the Treatment of Anxiety: A Systemic Review and Meta-Analysis. Front Psychiatry 2022. Read 2026-10-22.
- U.S. Food and Drug Administration. PMA database record P230024, Flow FL-100, decision date 12/08/2025. Read 2026-10-22.
- Efficacy of electrical cranial stimulation for treatment of psychiatric symptoms in patients with anxiety: A systematic review and meta-analysis. Front Psychiatry 2023. Read 2026-10-22.